ASQ-3
Showing 9976 - 10000 of >10,000
MDD Trial in Austin (Centanafadine (328.8 mg), Escitalopram, Placebo)
Recruiting
- Major Depressive Disorder
- Centanafadine (328.8 mg)
- +2 more
-
Austin, TexasFor additional information regarding sites, contact 844-687-8522
Sep 14, 2022
Cervical Paraspinal Muscle Twitching and Cervical Facet
Recruiting
- Cervical Facet Joint Pain
- +2 more
- Cervical Radiofrequency Ablation (RFA)
-
Baltimore, MarylandJohns Hopkins Hospital
Sep 13, 2022
Prediction of the Post-intensive Care Syndrome
Not yet recruiting
- Critical Care
- (no location specified)
Jan 10, 2023
Extreme Prematurity, Extremely Low Birth Weight, Very Low Birth Weight Infant Trial in Cork (Held Position)
Completed
- Extreme Prematurity
- +3 more
- Held Position
-
Cork, Munster, IrelandCork University Maternity Hospital, Wilton
Jan 16, 2023
Alcohol Drinking Trial in Hong Kong (Behavioral: EMA-based intervention)
Not yet recruiting
- Alcohol Drinking
- Behavioral: EMA-based intervention
-
Hong Kong, Hong KongLKS Faculty of Medicine
Jan 16, 2023
Acute Respiratory Tract Infections Trial in Hanoi (LiveSpo Navax, 0.9% NaCl physiological saline)
Completed
- Acute Respiratory Tract Infections
- LiveSpo Navax
- 0.9% NaCl physiological saline
-
Hanoi, VietnamInternational Center, Vietnam National Children's Hospital
Dec 18, 2021
Healthy Participants Trial in Brussels (PF-07899895, Placebo)
Not yet recruiting
- Healthy Participants
- PF-07899895
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Nov 14, 2023
OCD, EEG With Periodic Abnormalities Trial in Istanbul (Deep Transcranial Magnetic Stimulation, Paroxetine)
Active, not recruiting
- Obsessive-Compulsive Disorder
- EEG With Periodic Abnormalities
- Deep Transcranial Magnetic Stimulation
- Paroxetine
-
Istanbul, Beykoz, TurkeyIstanbul Medipol University
Dec 26, 2021
Type 2 Diabetes, Insomnia, Sleep Disorder Trial in Boston (Suvorexant, Placebo)
Active, not recruiting
- Type 2 Diabetes Mellitus
- +3 more
- Suvorexant
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Aug 31, 2021
Tooth Extraction Status Nos Trial in Nova Friburgo (Molar extraction - Control Group, aPDT + Molar Extraction - Test Group 1,
Completed
- Tooth Extraction Status Nos
- Molar extraction - Control Group
- +3 more
-
Nova Friburgo, Rio De Janeiro, BrazilLivia Antunes, PhD
Nov 27, 2022
Persistent Atrial Fibrillation Ablation Using Ablation
Not yet recruiting
- Persistent Atrial Fibrillation
- Ablation Index-guided ablation
- High-power, short-duration ablation using QDOT Micro catheter
- (no location specified)
Nov 27, 2022
Syncope, Neurogenic, Syncope Trial in Bonheiden, Brugge, Leuven (EPS, electro-anatomical mapping, ARGP ablation, and
Recruiting
- Syncope, Neurogenic
- Syncope
- EPS, electro-anatomical mapping, ARGP ablation, and pharmacological evaluation.
- EPS, electro-anatomical mapping, and pharmacological evaluation.
-
Bonheiden, Belgium
- +2 more
Oct 21, 2021
Pain, Function, Anxiety Trial in Iowa City (Acceptance and Committment Therapy (ACT), Attention Control (AC))
Recruiting
- Pain
- +5 more
- Acceptance and Committment Therapy (ACT)
- Attention Control (AC)
-
Iowa City, IowaIowa City VAMC
Oct 14, 2021
The Degree, Duration and Frequency of Insulin Resistance in
Completed
- Sepsis
- no intervention
-
Slagelse, DenmarkDepartment of endocrinology, Slagelse Hospiatl
Jul 9, 2021
Stroke Trial in Oxford (Neurofeedback, Sham Neurofeedback)
Terminated
- Stroke
- Neurofeedback
- Sham Neurofeedback
-
Oxford, United KingdomWellcome Centre for Integrative Neuroimaging (WIN)
Jul 19, 2021
Autism Spectrum Disorder, Autism, Autism Spectrum Disorders Trial in Atherton, Sunnyvale (Autism Family Empowerment Coaching and
Recruiting
- Autism Spectrum Disorder
- +6 more
- Autism Family Empowerment Coaching and Training Program
-
Atherton, California
- +1 more
Jun 23, 2023
Acute Uncomplicated Plasmodium Falciparum Malaria Trial in Worldwide (KAF156, Coartem, Lumefantrine Solid Dispersion
Completed
- Acute Uncomplicated Plasmodium Falciparum Malaria
- KAF156
- +2 more
-
Nanoro, Burkina Faso
- +10 more
Dec 21, 2021
Hand-foot-mouth Disease, Infection; Viral, Enterovirus Trial in Nanning (100U inactivated Enterovirus Type 71 Vaccine, 200U
Completed
- Hand-foot-mouth Disease
- Infection; Viral, Enterovirus
- 100U inactivated Enterovirus Type 71 Vaccine
- +3 more
-
Nanning, Guangxi, ChinaGuangXi Center for Diseases Control and Prevention
Jul 25, 2021
COPD Trial in Worldwide (Itepekimab SAR440340)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Itepekimab SAR440340
-
Oklahoma City, Oklahoma
- +11 more
Jan 17, 2023
Anxiety Disorders, Public Speaking Fear Trial in Los Angeles (Exposure, Rehearsal)
Enrolling by invitation
- Anxiety Disorders
- Public Speaking Fear
- Exposure
- Rehearsal
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Nov 9, 2023
Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- New Diagnosis Tumor
- Carfilzomib
- +2 more
-
Alessandria, Italy
- +41 more
Mar 24, 2022
Cystic Fibrosis Trial in Clermont-Ferrand, La Tronche, Pierre-Bénite (" Information-Motivation-Behavioral skills "
Recruiting
- Cystic Fibrosis
- " Information-Motivation-Behavioral skills " intervention.
-
Clermont-Ferrand, France
- +2 more
Mar 9, 2022
MDD, Bipolar Affective Disorder, Currently Depressed, Moderate Trial in Milan (Venlafaxine)
Recruiting
- Major Depressive Disorder
- Bipolar Affective Disorder, Currently Depressed, Moderate
-
Milan, MI, ItalyFondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Nov 8, 2023